US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Limes Schlosskliniken AG (LIK) 銘柄情報

Limes Schlosskliniken AG (LIK)

515.00

-15.00

(-2.83%)

終了 6月15日 5:00AM

Limes Schlosskliniken AG (LIK) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

515.00

( -2.83% )

買値

505.00

売値

525.00

出来高

723

494.00 日の範囲 545.00

300.00 52 週間の範囲 560.00

時価総額

前日終値

530.00

始値

530.00

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

82 €

発行済株式数

297,952

配当利回り

PER

27.21

1 株当たり利益 (EPS)

19.11

歳入

50M

純利益

5.69M

LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, and Liechtenstein. The company focuses on the treatment of stress-related illnesses; and mental and psychological disorders, such as depression, acute burnout, affect... LIMES Schlosskliniken AG operates private clinics for psychiatry, psychotherapy, and psychosomatics services in Germany, Switzerland, and Liechtenstein. The company focuses on the treatment of stress-related illnesses; and mental and psychological disorders, such as depression, acute burnout, affective disorders, trauma/PTSD, anxiety disorders, attention deficit hyperactivity disorder, personality disorder, chronic pain, psychoses, obsessive compulsive disorder, sleep disorder, somatoform disorder, and sports psychiatry. The company was formerly known as GMF Capital AG and changed its name to LIMES Schlosskliniken AG in December 2005. LIMES Schlosskliniken AG was founded in 2005 and is headquartered in Cologne, Germany. The company operates as a subsidiary of GMF Capital GmbH. 詳細を表示

セクター

Healthcare

業界

Healthcare Providers & Services

ウェブサイト

www.limes-schlosskliniken.de

本社

Cologne, Germany

設立

2026

Limes Schlosskliniken AG is listed in the Healthcare sector of the Tradegate (DE) with ticker LIK. The last closing price for Limes Schlosskliniken was 530.00 €. Over the last year, Limes Schlosskliniken shares have traded in a share price range of 300.00 € to 560.00 €.

Limes Schlosskliniken currently has 297,952 shares in issue. The market capitalisation of Limes Schlosskliniken is 153.45 € million. Limes Schlosskliniken has a price to earnings ratio (PE ratio) of 27.21.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	10	1.9801980198	505	560	492	172	525.12180974	DE
4	17	3.41365461847	498	560	488	134	515.1961223	DE
12	31	6.40495867769	484	560	456	105	499.56611362	DE
26	195	60.9375	320	560	320	113	456.04168785	DE
52	163	46.3068181818	352	560	300	77	431.49254724	DE
156	183	55.1204819277	332	560	234	41	401.89364378	DE
260	351	214.024390244	164	560	144	59	304.35259164	DE

LIK - Frequently Asked Questions (FAQ)

What is the current Limes Schlosskliniken AG share price?

The current share price of Limes Schlosskliniken AG is 515.00 €

How many Limes Schlosskliniken AG shares are in issue?

Limes Schlosskliniken AG has 297,952 shares in issue

What is the market cap of Limes Schlosskliniken AG?

The market capitalisation of Limes Schlosskliniken AG is EUR 153.45M

What is the 1 year trading range for Limes Schlosskliniken AG share price?

Limes Schlosskliniken AG has traded in the range of 300.00 € to 560.00 € during the past year

What is the PE ratio of Limes Schlosskliniken AG?

The price to earnings ratio of Limes Schlosskliniken AG is 27.21

What is the cash to sales ratio of Limes Schlosskliniken AG?

The cash to sales ratio of Limes Schlosskliniken AG is 3.1

What is the registered address of Limes Schlosskliniken AG?

The registered address for Limes Schlosskliniken AG is Kaiser-Wilhelm-Ring 26, Cologne, North Rhine-Westphalia, 50672

What is the Limes Schlosskliniken AG website address?

The website address for Limes Schlosskliniken AG is www.limes-schlosskliniken.de

Which industry sector does Limes Schlosskliniken AG operate in?

Limes Schlosskliniken AG operates in the Healthcare Providers & Services sector

joe botts

joe botts 3分前

Lol! Whew lunch and Applebee's for dinner money.

ddls

All this enthusiasm for a stock that trades 10 or less times a day. More posts than trades....hmmmmmmm!

joe botts

joe botts 5分前

No way what about Wertheim! Lmao

BIOChecker4

BIOChecker4 7分前

“CROs were responsible for the data and they are not combing through their work.“

You could not possibly know this. You are making a supposition that is not supported by any evidence.

As for no need to check every nook and cranny, the exact opposite is true. Every bit

luckydude777

luckydude777 9分前

Sure hope the "deal" is legit. Will be nice if it is.

BIOChecker4

BIOChecker4 11分前

Your logic is flawed. How would Dr. K. Know the AD data are good when the trials that generated the data were flawed? This is the reason large, well designed phase 3 trials are necessary and will be required by drug regulators.

theorysuit

theorysuit 11分前

Don't worry all the people posting on here are paid pumps. That's why they are apologizing and assigning blame to anyone but nwbo. No sane investor would be happy with this lying POS company who has failed in so many ways.

These small pumps for the company to offload thei

NYATC

Let hope they don’t “screw the pooch”. You know that one? 😆

AJH92

$ECOX Overview - Updated June 13, 2026

New CEO: Richard C Hawkins wef April 2, 2025

Reverse Merger With Kepler GTL

Letter of Intent to Combine [source: PR February 17, 2026]

- On February 12, 2026 entered into a non-binding Letter of Intent

ddls

This stock is finished, done, the end...but you go ahead and dream of something else.

HyGro

NWBO didn't have much choice. FDA took a pass, EU is more difficult, so UK looked like their best option.

The EU requires interaction with multiple bodies: EMA scientific assessment via rapporteurs, CHMP opinion, and then EC legal decision, plus subsequent national pricing/HTA negot

nwsun

Hopefully we all make a big gain on another investment and we can use sflm as a full write off against those gains.

theorysuit

theorysuit 16分前

Oh sure blame the mhra for it taking this long. Where are the other applications/submissions LP In promised 3 years ago. Do you want to blame that on MHRA too? Blame anyone else is their mantra .......lmfao. Is that why LP says they won't update on status? Protesting the rejection?Lmfao at

William777

William777 16分前

(Nutanomics) also known as NNI produced and branded its own product line, and began to sell to the retail outlets and to the public. NNI has also produced formulas for hundreds of other companies. Trademarks, Tradenames, and Patents: NNI®, NutraNomics®, HEC®, Health Education Corporation®, AES®, Ass

Vexari

Vexari 16分前

Brian's Song (1971)

This highly acclaimed winner of five Emmy Awards

It's the true story of a special relationship between two professional football players

Gale Sayers (Billy Dee Williams) and Bria

spartex

spartex 19分前

Hope everyone bought a lot of various calls on Friday, except for oil...lol!

Donald J. Trump
@realDonaldTrump
The Deal with the Islamic Republic of Iran is now complete. Congratulations to all! I hereby fully authorize the toll free opening of the Strait of Hormuz, and,

HGiLS

You are such a b* on ignore!!

Enough with negativity!!!

Look at the half full size of the glass for once.

26. Billion plus 800 million = 26.8 billion in r&d so far for /2026. And counting.

Someone else tell him he is so picky I wanna thro

mike papa

mike papa 19分前

Q. Pertaining to your 12 June 26 press release
at OTC Markets.How can you be all that you
claim to be with a $0.0042 stock price ?
SMKG est 1990's.

againstallodds

againstallodds 21分前

What’s the fuss? It’s 49% of NOTHING!!!

nwsun

It was proven during the 70s Church Hearings

Rick1997

Rick1997 22分前

Awesome read! Had 2 drinks reading!
Thank you!

stoxjock

stoxjock 22分前

EXACTLY... The Whole "WMI-LT" Thing was a SCAM! I knew from the Moment I heard that "EC" "Agreed to Let GO of the Insider Trading Charges" I"IN RETURN"
for "Setting up" a "WMI-LT" for "Litigating Other Charges" "ON-Behalf OF" "WaMu Equity_Holders" that MW & Co of the EC

"SOLD

God Bless America

God Bless America 23分前

Time may be calculated back from Christmas 2025 when President had dinner with institutions, banks, etc. Not from now.

ap17

Holy Moly 32 messages!! All great to see all the positive news, developments, etc.....BUT What's it going to take for this token, crypto, unit, etc to get out of it's own way. Long for 1yr plus.

Limes Schlosskliniken

AppTech Payments (QB)

American Homes 4 Rent

Investec Bnk 24

Janus Henderson Tabula J...

Golden Grail Technology (ID)

Truist Financial

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。